chr22-36875639-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000631.5(NCF4):c.628-14C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0173 in 1,609,904 control chromosomes in the GnomAD database, including 304 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 13 hom., cov: 32)
Exomes 𝑓: 0.018 ( 291 hom. )
Consequence
NCF4
NM_000631.5 intron
NM_000631.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.657
Publications
2 publications found
Genes affected
NCF4 (HGNC:7662): (neutrophil cytosolic factor 4) The protein encoded by this gene is a cytosolic regulatory component of the superoxide-producing phagocyte NADPH-oxidase, a multicomponent enzyme system important for host defense. This protein is preferentially expressed in cells of myeloid lineage. It interacts primarily with neutrophil cytosolic factor 2 (NCF2/p67-phox) to form a complex with neutrophil cytosolic factor 1 (NCF1/p47-phox), which further interacts with the small G protein RAC1 and translocates to the membrane upon cell stimulation. This complex then activates flavocytochrome b, the membrane-integrated catalytic core of the enzyme system. The PX domain of this protein can bind phospholipid products of the PI(3) kinase, which suggests its role in PI(3) kinase-mediated signaling events. The phosphorylation of this protein was found to negatively regulate the enzyme activity. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
NCF4 Gene-Disease associations (from GenCC):
- granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- chronic granulomatous diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 22-36875639-C-A is Benign according to our data. Variant chr22-36875639-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260305.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.012 (1829/152256) while in subpopulation SAS AF = 0.0278 (134/4812). AF 95% confidence interval is 0.024. There are 13 homozygotes in GnomAd4. There are 862 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NCF4 | NM_000631.5 | c.628-14C>A | intron_variant | Intron 7 of 9 | ENST00000248899.11 | NP_000622.2 | ||
| NCF4 | NM_013416.4 | c.628-14C>A | intron_variant | Intron 7 of 8 | NP_038202.2 | |||
| NCF4 | XM_047441384.1 | c.802-14C>A | intron_variant | Intron 8 of 10 | XP_047297340.1 | |||
| NCF4 | XM_047441385.1 | c.772-14C>A | intron_variant | Intron 8 of 10 | XP_047297341.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0120 AC: 1832AN: 152138Hom.: 13 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1832
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0152 AC: 3762AN: 247390 AF XY: 0.0164 show subpopulations
GnomAD2 exomes
AF:
AC:
3762
AN:
247390
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0178 AC: 26013AN: 1457648Hom.: 291 Cov.: 31 AF XY: 0.0184 AC XY: 13313AN XY: 725292 show subpopulations
GnomAD4 exome
AF:
AC:
26013
AN:
1457648
Hom.:
Cov.:
31
AF XY:
AC XY:
13313
AN XY:
725292
show subpopulations
African (AFR)
AF:
AC:
94
AN:
33468
American (AMR)
AF:
AC:
331
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
1042
AN:
26132
East Asian (EAS)
AF:
AC:
1
AN:
39690
South Asian (SAS)
AF:
AC:
2485
AN:
86252
European-Finnish (FIN)
AF:
AC:
280
AN:
49720
Middle Eastern (MID)
AF:
AC:
226
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
20309
AN:
1111558
Other (OTH)
AF:
AC:
1245
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1364
2728
4093
5457
6821
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
752
1504
2256
3008
3760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0120 AC: 1829AN: 152256Hom.: 13 Cov.: 32 AF XY: 0.0116 AC XY: 862AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
1829
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
862
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
117
AN:
41562
American (AMR)
AF:
AC:
136
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
127
AN:
3472
East Asian (EAS)
AF:
AC:
2
AN:
5178
South Asian (SAS)
AF:
AC:
134
AN:
4812
European-Finnish (FIN)
AF:
AC:
60
AN:
10614
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1218
AN:
67998
Other (OTH)
AF:
AC:
25
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
92
184
277
369
461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
54
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 11, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.